1 year return (CAGR)
34.30%
Nautilus Biotechnology Inc Exchange (NASDAQ, USD)
NAUT
0.95
-0.05 (-4.55%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-35.47%
5 year return (CAGR)
-33.08%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
121.39M
Price/Sales
638.89
Ent value
140.69M
Price/Book
0.93
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
156.61%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.00 |
| Daily high | 1.02 |
| Daily low | 0.95 |
| Daily Volume | 386K |
| All-time high | 22.43 |
| 1y analyst estimate | 4.00 |
| Beta | 0.87 |
| EPS (TTM) | -0.45 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| NAUT | S&P500 | |
| Current price drop from All-time high | -95.75% | -1.29% |
| Highest price drop | -97.15% | -56.47% |
| Date of highest drop | 3 Sep 2025 | 9 Mar 2009 |
| Avg drop from high | -78.13% | -10.68% |
| Avg time to new high | 90 days | 12 days |
| Max time to new high | 1413 days | 1805 days |
News
